Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses

Anesthesiology

Volumn 99, Issue 1, 2003, Pages 42-47

  Kasper, Stefan Mario ^a   Meinert, Philipp ^a   Kampe, Sandra ^a   Görg, Christoph ^a   Geisen, Christof ^a   Mehlhorn, Uwe ^a   Diefenbach, Christoph ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b St Katharinen Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOSE CALCULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; ERYTHROCYTE TRANSFUSION; FEMALE; HETASTARCH; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PLASMA SUBSTITUTES;

EID: 0038449992     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200307000-00010     Document Type: Article

References (19)

1. Harker LA: Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314:1446-8
2. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, Mullany CJ: Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000; 90:801-7
3. Wilkes MM, Navickis RJ, Sibbald WJ: Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72:527-34
4. Warren BB, Durieux ME: Hydroxyethyl starch: Safe or not? Anesth Analg 1997; 84:206-12
5. Treib J, Baron JF, Grauer MT, Strauss RG: An international view of hydroxyethyl starches. Intensive Care Med 1999; 25:258-68
6. De Jonge E, Levi M: Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 2001; 29:1261-7
7. Franz A, Bräunlich P, Gamsjäger T, Felfemig M, Gustorff B, Kozek-Langenecker SA: The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92:1402-7
8. Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR: In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Anesth Analg 2000; 90:274-9
9. Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR: Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000; 44:1116-21
10. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR: Compromised blood coagulation: An in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998; 87:989-93
11. Royston D: High-dose aprotinin therapy: A review of the first five years' experience. J Cardiothorac Vasc Anesth 1992; 6:76-100
12. American Society of Anesthesiologists Task Force on Blood Component Therapy: Practice guidelines for blood component therapy. ANESTHESIOLOGY 1996; 84:732-47
13. Schaff HV, Hauer JM, Bell WR, Gardner TJ, Donahoo JS, Gott VL, Brawley RK: Autotransfusion of shed mediastinal blood after cardiac surgery. J Thorac Cardiovasc Surg 1978; 75:632-41
14. Carter RF, McArdle B, Morritt GM: Autologous transfusion of mediastinal drainage blood. Anaesthesia 1981; 36:54-9
15. Hartz RS, Smith JA, Green D: Autotransfusion after cardiac surgery. J Thorac Cardiovasc Surg 1988; 96:178-82
16. Goodnough LT, Bravo JR, Hsueh Y, Keating LJ, Brittenham GM: Red blood cell mass in autologous and homologous blood units. Transfusion 1989; 29:821-2
17. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A, Schobersberger W: The effect of combined administration of colloids and lactated Ringer's solution on the coagulation system: An in vitro study using Thrombelastograph® coagulation analysis (ROTEG®). Anesth Analg 2002; 94:1280-7
18. Gallandat Huet RCG, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JAM, van Oeveren W, Bepperling F: A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47:1207-15
19. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F: Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15:316-21